First quarter - Introduction underway
First Quarter 2021 · Revenue amounted to SEK 405 (6,269) thousand, of which SEK 378 (6,303) thousand were capitalized costs. · Cash flow from operating activities amounted to SEK -10,510 (-9,534) thousand. · Loss after tax amounted to SEK -17,261 (-7,235) thousand. · Loss per share SEK -0.29 (-0.41). · The equity / assets ratio was 94 (78) percent. Significant events during the quarter ·The European Patent Office EPO issued a European patent for the company's pulse biopsy instrument, including a multifunctional handset that can be used for several different types